Track Evoke Pharma, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Evoke Pharma, Inc. EVOK · Stock Open Evoke Pharma, Inc. in new tab

11.00 USD
Add to portfolio
EPS
-1.38
P/B
7.06
ROE
-134.88
Beta
-0.14
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
EPS-1.38
Book Value1.56
Price to Book7.06
Debt/Equity152.05
% Insiders10.621%
Growth
Revenue Growth0.61%
Estimates
Forward P/E16.18
Forward EPS0.68

DCF Valuation

Tweak assumptions to recompute fair value for Evoke Pharma, Inc. (EVOK)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Evoke Pharma, Inc. Logo Evoke Pharma, Inc. Analysis (EVOK)

United States Health Care Official Website Stock

Is Evoke Pharma, Inc. a good investment? Evoke Pharma, Inc. (EVOK) is currently trading at 11.00 USD.

Investor FAQ

Does Evoke Pharma, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Evoke Pharma, Inc.?

Evoke Pharma, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California. As of December 15, 2025, Evoke Pharma, Inc. operates as a subsidiary of QOL Medical, LLC.

Exchange Ticker
FRA (Germany) EV0.F
NMS (United States) EVOK
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
May 23, 2022 1:12
Aug. 1, 2024 1:12
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion